GNI Group Ltd. (TYO:2160)
2,480.00
-109.00 (-4.21%)
May 21, 2025, 3:30 PM JST
GNI Group Revenue
GNI Group had revenue of 5.32B JPY in the quarter ending March 31, 2025, a decrease of -10.56%. This brings the company's revenue in the last twelve months to 22.98B, down -17.18% year-over-year. In the year 2024, GNI Group had annual revenue of 23.61B, down -9.22%.
Revenue (ttm)
22.98B
Revenue Growth
-17.18%
P/S Ratio
5.66
Revenue / Employee
26.51M
Employees
867
Market Cap
130.00B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 23.61B | -2.40B | -9.22% |
Dec 31, 2023 | 26.01B | 8.59B | 49.33% |
Dec 31, 2022 | 17.42B | 4.73B | 37.26% |
Dec 31, 2021 | 12.69B | 2.92B | 29.85% |
Dec 31, 2020 | 9.77B | 2.33B | 31.25% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Daiichi Sankyo Company | 1,886.26B |
Takeda Pharmaceutical Company | 4,581.55B |
HOYA Corporation | 869.37B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 997.33B |